Pharmaceuticals, Biotechnology and Life Sciences
LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), the world’s largest provider of HIV/AIDS care globally, applauded today President Biden’s historic decision…
– ZYNLONTA is the first and only CD19-targeted ADC approved as a single-agent treatment for adult patients with r/r DLBCL…
Investigational New Drug (IND) Application Submitted for Phase 2/3 AIS Study Plan to Initiate Phase 2/3 AIS Trial in Summer…
Shareholders URGED to Vote the BLUE proxy by 9:00 a.m. on May 12, 2021 TORONTO–(BUSINESS WIRE)–$HUGE–FSD Pharma Inc. (the “Company”)…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…
Continued to advance our portfolio of anti-TIGIT antibodies: On track for the ARC-7 interim analysis for domvanalimab in 2Q21, and…
KEYTRUDA Is the First Anti-PD-1 Therapy Approved in Combination With Trastuzumab and Chemotherapy for the First-line Treatment of These Patients…
– REVTx-99 stimulated significant production of Interferon-Induced Protein-10 (IP-10)- -All doses of REVTx-99 were well tolerated with no significant or…
— Management to Host Conference Call at 4:30 p.m. ET Today — MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical…